Business Context and Reporting Period
This Form 8-K Current Report was filed by LiqTech International, Inc., a Nevada corporation, on April 14, 2015. The report discloses a corporate governance event regarding the appointment of a new Board member.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance data.
Material Changes
The material change reported is the appointment of Dr. Rengarajan Ramesh to the Board of Directors, effective April 14, 2015. As compensation for his service, Dr. Ramesh will receive a stock grant of 100,000 shares, scheduled to vest over a 3-year period.
Outlook, Commentary, and Risks
Management commentary highlights Dr. Ramesh's extensive background, including over 30 years of global operating and technology experience. His resume includes senior roles at GE Water & Process Technologies (where he served as CTO and helped create a $2.5 billion global water platform) and A. Schulman Inc. He also holds advisory roles with Wasserstein & Co., United Technologies Corporation, and various government and non-profit water initiatives. The filing does not explicitly state new risks or contingencies beyond the standard disclosure of the appointment.
Investor Verification Checklist
- Verify the vesting schedule and terms of the 100,000-share stock grant issued to Dr. Ramesh.
- Confirm the effective date of Dr. Ramesh's board membership (April 14, 2015).
- Review the attached Press Release (Exhibit 99.1) for additional details on the appointment.
- Check subsequent filings for any changes to the Board composition or executive compensation plans.